Skip to main content
Equibles
UROY logo

UROY · Uranium Royalty Corp. · Metrics

Track UROY — free

Use UROY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research UROY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.57 -0.13 (-3.51%) At close · Oct 28
Rebalance outlook locked
Going-concern doubt — flagged Sep 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions and events raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that these unaudited condensed consolidated financial statements are issued. Accordingly, management has concluded that its plans do not alleviate this substantial doubt.”
View the 10-Q filed Sep 14, 2026
Customer concentration — key customers 100% of revenue

Key customers — 100% of revenue (the years ended April 30, 2026 and 2025)

“100% of the royalty revenue for the years ended April 30, 2026 and 2025 is from Langer Heinrich.”
View the 10-K filed Jul 28, 2026
Market Cap
$1.33B
Shares
377.21M
Volume · Oct 28 2.88M Avg daily vol (3M) 3.31M

UROY metrics

74 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.57
Market cap
$1.33B

Price action

20 metrics
Price change (1W)
+6.3%
Price change (30D)
-7.5%
Price change (3M)
+33.1%
Price change (6M)
+0.8%
Price change (YTD)
+4.5%
Price change (1Y)
-9.3%
Trailing year
Price change (5Y)
-28.4%
52-week high
$5.46
52-week low
$2.61
Change from 52-week high
-32.2%
Change from 52-week low
+41.8%
Annualized volatility
70.0%
Annualized volatility (3M)
63.6%
Beta
2.4
RSI (14D)
46.0
Price vs SMA 50
-10.1%
Price vs SMA 200
-1.9%
Avg volume (3M)
3.31M
Relative volume
1.2
Average dollar volume
$13.54M

Company

3 metrics
Sector
Energy
Industry
Uranium
Shares outstanding
377.21M

Valuation

12 metrics
P / E (TTM)
24.5
Trailing earnings · reciprocal yield 4.1%
PEG ratio
0.0
EV / revenue
8.7×
reciprocal yield 11.5%
EV / EBITDA
29.6×
reciprocal yield 3.4%
EV / EBIT
29.7×
reciprocal yield 3.4%
P / sales
6.4×
reciprocal yield 15.7%
P / book
1.4
reciprocal yield 70.9%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
6.5
reciprocal yield 15.3%
Earnings yield
4.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
29.3%
Trailing 12 months
Net margin
26.0%
Gross profit (TTM)
—
Operating profit (TTM)
$62.48M
Net income (TTM)
$55.47M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
27.3%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.83

Growth

11 metrics
Revenue growth YoY
+110.2%
Year over year
Net income growth YoY
+1,485.1%
Revenue (TTM)
$213.53M
Trailing 12 months
EPS growth YoY
+900.0%
Shares change YoY
+17.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
5.8%
Return on assets
2.9%
Debt / equity
0.6
Current ratio
0.9
EBITDA (TTM)
$62.75M
Free cash flow (TTM)
—
Quick ratio
0.9
Interest coverage
125.2
Net debt / EBITDA
7.9
Return on invested capital
3.1%
Trailing 12 months
Net cash
−$498.66M
Latest balance sheet
Cash & equivalents
$54.10M
Total assets
$1.91B
Total debt
$552.76M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$208.01M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
$4.92M
Stock compensation (TTM)
$762,000
R&D / revenue
—
Stock compensation / revenue
0.4%

Ownership (13F)

9 metrics
13F filers
113
13F filer change QoQ
+3
Institutional ownership
10.8%
Conviction holders (share of 13F filers)
0.9%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-13.1%
Holder tenure
8.5
Price vs estimated holder cost
-15.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
3.4%

Short interest

3 metrics
Short interest
3.7%
Latest settlement · 4.9 days to cover
Days to cover
4.9d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 2143673 CUSIP 91703D100 13F (30d) 12 filings 12 filers Visit website Investor relations